Tele: 561.316.3330
Breaking Medical Device News

Monday, September 20, 2021

MEDICAL DEVICE NEWS MAGAZINE

A DIGITAL PUBLICATION FOR THE PRACTICING MEDICAL SPECIALIST, INDUSTRY EXECUTIVE AND INVESTOR
HomeFlow RoboticsFlow Robotics Establishes No. American Subsidiary with Operations in Princeton, NJ

Flow Robotics Establishes No. American Subsidiary with Operations in Princeton, NJ

Flow Robotics, is a Denmark-based leading designer and producer of robots for automated liquid handling and the creator of the flowbot® ONE.

Today the company announced today that it has established its North American Subsidiary, Flow Robotics, Inc., with operations in Princeton, NJ. The company’s first product, the flowbot® ONE, is designed to transform how liquid handling responsibilities are performed in the laboratory by automating manual pipetting tasks. The robot will be showcased for the first time in the U.S. at the SLAS 2021 Americas Sample Management Hybrid Symposium September 9-10 in La Jolla, CA.

Flow Robotics Establishes No. American Subsidiary with operations in Princeton, NJ
The flowbot® ONE from Flow Robotics transforms how liquid handling responsibilities are performed in the laboratory by automating manual pipetting tasks.

The flowbot® ONE debuts at a pivotal moment for the laboratory industry plagued for years with high workloads, burnout, and physically challenging conditions recently exacerbated by the COVID-19 outbreak. The pandemic brought an increased necessity for collecting and preparing virus samples quickly, safely, and accurately.

“We are excited to expand our operations in North America,” said Annika Isaksson, CEO of Flow Robotics. “Our technology is setting a global precedent in life sciences, healthcare and academia, delivering faster and more accurate lab results. The flowbot® ONE helps labs achieve a more sustainable setup by taking over many of the repetitive and burdensome manual pipetting tasks. In turn, lab personnel can engage in other more valuable activities. flowbot® ONE also reduces human error and work-related injuries, resulting in an overall increase in lab productivity, where humans and robots can work in parallel.”

Flow Robotics estimates that about half of medical lab technicians carry out the same arm movements for at least a quarter of their working day. Manual pipetting is a large part of liquid handling in any laboratory, and it brings hours of repetitive work in fixed positions. This can result in physical strain to the shoulders, arms and hands. The American Society for Clinical Pathology found that 85 percent of laboratory professionals suffer from burnout; 36 percent struggle with inadequate staffing; and 32 percent face a heavy workload and pressure to complete all testing on time.

Flexible Ease of Use and Adaptability to Perform Multiple Tasks

Unlike other automated liquid handling robots, flowbot® ONE does not require advanced programming skills so just about anyone can set up a procedure. The robot also has the ability to integrate to devices positioned on the deck or external to the system. It also supports the import and export of data.

In addition, flowbot® ONE can play a role in many different pipetting applications and tasks in the lab. This includes, PCR and qPCR, normalization, sample aliquoting, microplate filing, next generation sequencing (NGS), ELISA sample preparation, assay development, screening, reformatting, cherry picking, transferring, serial dilution, plate replication and reformatting.

“We continue to see the need for more flexibility in robotics automation in clinical and research labs across the world,” said Craig Cardella, Vice President and General Manager for Flow Robotics’ new North American division. “I am excited to bring this capability to labs in North America with flowbot® ONE to help increase productivity and change the way they do business.”

“The flowbot® ONE’s intuitive and flexible system is in use at some of the largest hospitals, biotech and pharmaceutical companies and academic research labs across the world, and we look forward to seeing the same success in North America,” continued Isaksson.

Plays Integral Role in Fight Against COVID-19

Since May 2020, the flowbot® ONE has played an integral role in the fight against COVID-19 by speeding up the analysis of COVID-19 tests while keeping laboratory assistants safe. Today, more than 600,000 COVID-19 tests are being prepared each month on a flowbot® ONE in Europe, where the robots pipette the live virus, handling several samples simultaneously, all working from a predefined pipetting pattern.

Significant Increases in Lab Productivity

Unilabs, one of the largest diagnostic providers in Europe, uses five flowbot™ ONE robots to help screen sclerosis patients for viruses. The flowbot™ ONE has helped to increase lab productivity by 40 percent and reduced the time patients need to wait for results by 30 percent.

Nordic Bioscience, a biomarker powerhouse that develops novel biomarkers and performs clinical trials, automated their clinical lab equipment with the flowbot® ONE to help optimize the work process and reduce pipetting for biomarker measurements. Hands-on lab time was reduced from 2 hours and 15 minutes to 20 minutes when running up to 8 biomarkers simultaneously in the lab.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Mark Foster Joins Xenocor BOD

Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

Gynesonics Announces FDA Clearance of Next Generation Sonata System

“This clearance brings significant system improvements that expand the location of fibroids that can be treated while allowing the physician to control all aspects of the treatment from within the sterile field,” said Jiayu Chen, Ph.D. Vice President, Engineering and Advanced Technologies at Gynesonics.

Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL

The new investment will enable the development and translation of a new ANI through preclinical studies and later, a pilot clinical trial, where the ANI is then implanted in up to three deaf patients.

Jonathan Chapman: New President/CEO of Trividia Health

Chapman said, “I’m honored to join the Trividia team as President and CEO. This organization has a long history of leadership within the healthcare industry as a provider of accurate, accessible, and affordable point-of-care solutions for the management of diabetes.”

SOLOPASS® System (Bedside Neuro-Navigation Device) Receives FDA 510(k) Clearance

inTRAvent’s SOLOPASS® system brings simple, portable, bedside neuro-navigation into the intensive care unit.

By using this website you agree to accept Medical Device News Magazine Privacy Policy